Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Ex Input:
Most cases are reported in the northern and eastern panhandles probably because of their proximity to the high-incidence states of Maryland, Pennsylvania, and Virginia, the Department of Health and Human Resources said. In an advisory Monday to health care providers, Health Commissioner Dr. Rahul Gupta wrote that the increase could be from increased reporting or from more ticks infected with the bacteria. Most cases appear between May and September, but ticks have become more active in winter months, he said. According to the department, 580 cases have been reported so far this year, up from 97 statewide in 2012. "Based on the change, West Virginia is considered a high incidence Lyme disease state," Gupta wrote. Patients treated early with antibiotics usually recover quickly. He recommended a two-step blood test to confirm evidence of antibodies against the Lyme disease bacteria. Symptoms often include a circular rash around a tick bite and fever, headaches and fatigue, according to the U.S. Centers for Disease Control. If left untreated, the infection can spread to joints, the heart and the nervous system. The CDC says there were more than 36,000 probable cases in the U.S. last year, with 26,203 confirmed.

Ex Output:
West Virginia reports increasing Lyme disease cases.

Ex Input:
One new study found that heart attack survivors benefited from a medicine long used to treat gout. Several experimental drugs also showed early promise for interfering with heart-harmful genes without modifying the genes themselves in one case, with treatment just twice a year. The research was featured at an American Heart Association conference ending Monday in Philadelphia. "There's a lot of excitement" about the new gene-targeting medicines, especially because they seem to last so long, said Dr. Karol Watson, of the University of California, Los Angeles. Scientists have been exploring gene therapy altering DNA to attack the root cause of many diseases. The new drugs essentially accomplish the same thing without tampering with genes, said the University of Pennsylvania's Dr. Daniel Rader, who has consulted for some makers of these drugs. The medicines work by silencing or blocking messages that genes give to cells to make proteins that can do harm, such as allowing cholesterol to accumulate. The first few of these "RNA-interference" drugs recently were approved for other conditions, and research is also targeting heart disease. Farthest along is inclisiran, tested in 1,561 people with heart disease from clogged arteries who still had high LDL, the bad form of cholesterol, despite taking standard drugs. They were given a shot of inclisiran or a dummy drug when they joined the study, three months later and then every six months. The drug lowered LDL by 56% without serious side effects. More testing will show whether it also lowers heart attacks and other problems, not just cholesterol. Inclisiran's maker, The Medicines Company, plans to seek federal approval for it later this year. Two other RNA interference drugs aim at a different target triglycerides, another fat in the blood that's elevated in one quarter of Americans. Treatments include very low-fat diets, weight loss, fish oil and drugs, but doctors say more and better therapies are needed. Each RNA interference drug was tested at various doses in 40 people. A single shot lowered triglycerides by 30% to 67%, and the benefit lasted for at least four months. The studies were just intended to show safety; Arrowhead Pharmaceuticals is developing both drugs. Other research found new benefits from older drugs. AstraZeneca's Farxiga, originally developed to treat diabetes, also lowered the risk of heart problems in heart failure patients who did not have diabetes. Among 2,605 of such patients treated for 18 months, about 9% of those on Farxiga had worsening heart failure or heart-related death versus nearly 13% of those not given the drug. That worked out to a 27% lower risk, without extra serious side effects. Surprising benefits also were seen in a Canadian study of the decades-old gout drug. The anti-inflammatory drug colchicine sold as Colcrys, Mitigare and in generic form was tested in 4,745 people who recently had a heart attack. After about two years, colchicine users had a 23% lower risk of suffering a new heart attack, heart-related death, stroke, cardiac arrest or urgent need for an artery-opening procedure compared with a group given dummy pills. The benefit came mostly from preventing strokes and artery-opening procedures, and some heart doctors would rather have seen more difference in heart attacks and deaths. Colchicine is being tested in several other studies, and more evidence is needed before using it routinely to lower heart risks, Dr. L. Kristin Newby of Duke University wrote in a commentary published with the study in the New England Journal of Medicine. Dr. Donald Lloyd-Jones, a Northwestern University cardiologist and program chief for the heart conference, was more supportive. "When you have a safe drug that's easily available, it's going to be hard to hold this one back," he said. ___ Marilynn Marchione can be followed on Twitter at http://twitter.com/MMarchioneAP ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.

Ex Output:
New, old drugs may offer fresh ways to fight heart disease.

Ex Input:
"Hostilities between the dairy industry and its competitors are flaring anew as alternatives to cow's milk take up more space in the dairy case. That means the politicians can't be far behind. U.S. Sen. Tammy Baldwin, a Wisconsin Democrat, spoke up Jan. 12, 2017 in a news release lauding herself as somebody who ""stands up for Wisconsin dairy farmers."" Baldwin wants Congress to pass the Dairy PRIDE Act -- officially known (at least to a few) as the ""Defending Against Imitations and Replacements of Yogurt, milk, and cheese to Promote Regular Intake of Dairy Everyday Act."" After two years of falling milk prices, she and other federal lawmakers want the U.S. Food and Drug Administration to enforce consumer regulations defining ""milk."" Is Baldwin right that imitation dairy products -- for instance, soy milk -- often differ nutritionally from dairy item? And is labeling them ""milk"" or ""cheese"" or ""yogurt"" against the law? To back that up, Baldwin's office pointed us to nutritional labels, and to FDA regulations that plainly state: ""Milk is the lacteal secretion, practically free from colostrum, obtained by the complete milking of one or more healthy cows."" 'Against the law' To dairy officials, inclusion of the word ""milk"" on non-dairy products is a misappropriation of the popularity of cow's milk. But competitors say coconut milk and soy milk have long histories and aren't confused with dairy. What's more, they note, the FDA doesn't punish ""peanut butter"" for using the dairy term ""butter."" But the FDA in 2008 and 2012 did tell two makers of drinks labeled ""soy milk"" that under its regulations, such labeling was inappropriate because the products did not contain ""milk"" as defined by the agency. ""Soy drink"" or ""Soy beverage"" would be better, the agency said at the time. That -- and regulatory language allowing the FDA to declare a product misbranded and try to block its sale -- help Baldwin's case. Federal regulations are part of the United States Code that is the law of the land. But to the frustration of the dairy industry, the agency has not consistently enforced that line of reasoning, allowing use of ""soy milk"" and ""almond milk"" and many others. Rebecca Cross, a San Francisco-based regulatory lawyer for food product companies, said the FDA may be viewing labels on a case-by-case basis and allowing use of dairy terms on plant-based products so long as the use is not misleading. Nathan Beaver, a food and drug lawyer with Foley & Lardner in Washington, D.C., explained that foods such as soy milk that have no FDA-written ""standard of identity"" must choose a ""common or usual"" name for their products. Courts, though, have jurisdiction over disputes on the issue and therefore get final say on the meaning of the FDA rules. On milk, courts so far have found that cow's milk competitors are not misbranded if their names don't confuse consumers, said Cross. The nutrition comparison Dairy alternatives, Baldwin said, ""contain a range of ingredients and nutrients that are often not equivalent to the nutrition content of dairy products."" This is a bit tricky to evaluate given that beverages labeled as some kind of ""milk"" now come from such diverse sources as soy, almonds, cashews, hemp, rice, oats, coconut and sunflowers. For help, we turned to Vandana Sheth, a registered dietician and spokesperson for the Academy of Nutrition and Dietetics, a leading organization of food and nutrition professionals. For starters, Sheth noted that dairy products can be a good source of calcium, vitamin D, protein and other essential nutrients. Soy milk provides close to the same amount of protein as cow's milk. Rice milk typically provides minimal protein and is higher in carbohydrates. Almond milk is usually quite low in protein and also less calorically dense, she said. Plant protein tends to be of a lower quality than dairy proteins, though soy is close, said John Lucey, a food scientist who directs the Center for Dairy Research at the University of Wisconsin-Madison. Our own review of labels found that soy and almond beverages, like cow's milk, are all relatively low calorie, low carbohydrate, low sodium drinks. They are all heavy with calcium. But they feature a different mix of vitamins and minerals, and fat content. Examples: soy milk has a lot of folate, while cow's milk typically has none; cow's milk contains some Vitamin C, but the soy, almond and hemp drinks we examined have none. Almond and soy milks feature some iron and fiber -- nutrients typically not found in cow's milk. ""All the products profile differently,"" said Susan Levin, a registered dietitian and director of nutrition education for the Washington, D.C.-based Physicians Committee for Responsible Medicine. Bottom line: Baldwin's nutrition observation is on target, based on a comparison of milk products. Our rating Baldwin claimed that imitation dairy products made from plants often differ nutritionally from the real thing, and labeling them ""milk"" or ""cheese"" or ""yogurt"" is ""against the law."" The nutrition point is accurate, and the legal point is partially so."

Ex Output:
Imitation dairy products often differ nutritionally from those they mimic, and labeling them "milk" or "cheese" or "yogurt" is "against the law.